Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants

Gemino Fiorelli, Franco Martinez Di Montemuros, Maria Domenica Cappellini

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect, being present in over 400 million people world wide. In a small number of cases, G6PD deficiency can lead to mild-to-severe chronic haemolysis, which is further exacerbated by oxidative stress. Such G6PD variants have been described all over the world and are responsible for chronic non-spherocytic haemolytic anaemia (CNSHA). To date 61 G6PD molecular variants associated with CNSHA have been identified, only some of which can cause the severe reduction in stability of the red blood cell enzyme. The distribution of the different mutations shows a predominance of small mutational events, and many have been found repeatedly in different parts of the world. By revisiting the 61 class 1 variants described so far, we can observe that a low inhibition constant (K i) for NADPH, a higher K m for substrates and a reduced thermostability are common.

Original languageEnglish
Pages (from-to)39-55
Number of pages17
JournalBest Practice and Research: Clinical Haematology
Volume13
Issue number1
DOIs
Publication statusPublished - 2000

Fingerprint

Glucosephosphate Dehydrogenase Deficiency
Glucosephosphate Dehydrogenase
Hemolytic Anemia
Enzymes
Hemolysis
NADP
Oxidative Stress
Erythrocytes
Mutation
Oxidative stress
Blood
Cells
Defects
Substrates

Keywords

  • Chronic anaemia
  • Chronic non-spherocytic haemolytic anaemia
  • DNA mutations
  • Glucose-6-phosphate dehydrogenase
  • Glucose-6-phosphate dehydrogenase variants
  • Haemolysis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants. / Fiorelli, Gemino; Martinez Di Montemuros, Franco; Cappellini, Maria Domenica.

In: Best Practice and Research: Clinical Haematology, Vol. 13, No. 1, 2000, p. 39-55.

Research output: Contribution to journalArticle

@article{a5cd8c2ed3734fd6aecaf2795a817ee8,
title = "Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants",
abstract = "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect, being present in over 400 million people world wide. In a small number of cases, G6PD deficiency can lead to mild-to-severe chronic haemolysis, which is further exacerbated by oxidative stress. Such G6PD variants have been described all over the world and are responsible for chronic non-spherocytic haemolytic anaemia (CNSHA). To date 61 G6PD molecular variants associated with CNSHA have been identified, only some of which can cause the severe reduction in stability of the red blood cell enzyme. The distribution of the different mutations shows a predominance of small mutational events, and many have been found repeatedly in different parts of the world. By revisiting the 61 class 1 variants described so far, we can observe that a low inhibition constant (K i) for NADPH, a higher K m for substrates and a reduced thermostability are common.",
keywords = "Chronic anaemia, Chronic non-spherocytic haemolytic anaemia, DNA mutations, Glucose-6-phosphate dehydrogenase, Glucose-6-phosphate dehydrogenase variants, Haemolysis",
author = "Gemino Fiorelli and {Martinez Di Montemuros}, Franco and Cappellini, {Maria Domenica}",
year = "2000",
doi = "10.1053/beha.1999.0056",
language = "English",
volume = "13",
pages = "39--55",
journal = "Best Practice and Research in Clinical Haematology",
issn = "1521-6926",
publisher = "Bailliere Tindall Ltd",
number = "1",

}

TY - JOUR

T1 - Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants

AU - Fiorelli, Gemino

AU - Martinez Di Montemuros, Franco

AU - Cappellini, Maria Domenica

PY - 2000

Y1 - 2000

N2 - Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect, being present in over 400 million people world wide. In a small number of cases, G6PD deficiency can lead to mild-to-severe chronic haemolysis, which is further exacerbated by oxidative stress. Such G6PD variants have been described all over the world and are responsible for chronic non-spherocytic haemolytic anaemia (CNSHA). To date 61 G6PD molecular variants associated with CNSHA have been identified, only some of which can cause the severe reduction in stability of the red blood cell enzyme. The distribution of the different mutations shows a predominance of small mutational events, and many have been found repeatedly in different parts of the world. By revisiting the 61 class 1 variants described so far, we can observe that a low inhibition constant (K i) for NADPH, a higher K m for substrates and a reduced thermostability are common.

AB - Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect, being present in over 400 million people world wide. In a small number of cases, G6PD deficiency can lead to mild-to-severe chronic haemolysis, which is further exacerbated by oxidative stress. Such G6PD variants have been described all over the world and are responsible for chronic non-spherocytic haemolytic anaemia (CNSHA). To date 61 G6PD molecular variants associated with CNSHA have been identified, only some of which can cause the severe reduction in stability of the red blood cell enzyme. The distribution of the different mutations shows a predominance of small mutational events, and many have been found repeatedly in different parts of the world. By revisiting the 61 class 1 variants described so far, we can observe that a low inhibition constant (K i) for NADPH, a higher K m for substrates and a reduced thermostability are common.

KW - Chronic anaemia

KW - Chronic non-spherocytic haemolytic anaemia

KW - DNA mutations

KW - Glucose-6-phosphate dehydrogenase

KW - Glucose-6-phosphate dehydrogenase variants

KW - Haemolysis

UR - http://www.scopus.com/inward/record.url?scp=0034430020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034430020&partnerID=8YFLogxK

U2 - 10.1053/beha.1999.0056

DO - 10.1053/beha.1999.0056

M3 - Article

C2 - 10916677

AN - SCOPUS:0034430020

VL - 13

SP - 39

EP - 55

JO - Best Practice and Research in Clinical Haematology

JF - Best Practice and Research in Clinical Haematology

SN - 1521-6926

IS - 1

ER -